• Advantages of Our Method

Our license out subjects

The following licenses are available since we have obtained an exclusive license for patents from Saitama Medical University.

  • ■ Diagnostic methods and diagnostic kite for predicting the effects of PD-1 and PD-L1 inhibitors
  • ■ Cancer immunotherapeutic agents given to specific patient groups selected with the above diagnostic methods
  • ■ Cell therapy that turns patients in the ineffective group of cancer immunotherapy into effective groups
  • ■ Others (contact us)

We shall accept the commissioned analysis and joint research regarding:

  • ■ Immune cell monitoring (blood and others)
  • ■ Search for novel biomarkers